Emerging Strategies in Metalloproteomics

被引:0
|
作者
Hagedoorn, Peter-Leon [1 ]
机构
[1] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The impact of changing metal ion concentrations on infection with a pathogenic microorganism has been established in several cases. To understand the molecular basis of the interplay between metals in the host and the pathogen in infectious diseases, metalloproteomics may prove to be a very powerful approach. Metalloproteomics is the comprehensive analysis of all metal-binding and metal-containing proteins in a biological sample. Strategies in metalloproteomics can be divided into experimental and computer-based approaches. Samples that have been analyzed using metalloproteomics strategies are cell lysates, subcellular fractions, and recombinantly expressed proteins from structural genomics platforms. Samples can be enriched in metal-binding protein by using immobilized metal ion affinity chromatography ( IMAC). Subsequently, metalloproteins have been separated using either 2D electrophoresis or 2D liquid chromatography ( LC). Resolved proteins have been further analyzed for metals and protein content. Inductively coupled plasma mass spectrometry ( ICP-MS), X-ray absorbance or fluorescence and autoradiography of radioactive metal isotopes have been used to determine the metal content, and different soft ionization mass spectrometry techniques and SDS-PAGE have been used to determine or quantify protein content. Computer-based strategies have been developed to predict metalloproteomes from genomes based on information from literature resources and different genomic and protein structural databases. Many of the methods presented here are comprehensive in nature. The interplay of computer-based and experimental strategies in metalloproteomics will significantly advance the field in the near future.
引用
收藏
页码:311 / 322
页数:12
相关论文
共 50 条
  • [21] Emerging strategies for the treatment of gastroparesis
    Langworthy, James
    Parkman, Henry P.
    Schey, Ron
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (07) : 817 - 825
  • [22] Emerging strategies for cancer immunoprevention
    Roeser, J. C.
    Leach, S. D.
    McAllister, F.
    ONCOGENE, 2015, 34 (50) : 6029 - 6039
  • [23] Emerging strategies for treating metastasis
    Mark Esposito
    Shridar Ganesan
    Yibin Kang
    Nature Cancer, 2021, 2 : 258 - 270
  • [24] Emerging strategies for treating gout
    Huddleston, Edward M.
    Gaffo, Angelo L.
    CURRENT OPINION IN PHARMACOLOGY, 2022, 65
  • [25] Emerging pharmacotherapeutic strategies for cholangiocarcinoma
    Dasanu, Constantin A.
    Majumder, Shounak
    Trikudanathan, Guru
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (12) : 1865 - 1874
  • [26] Psoriasis: emerging therapeutic strategies
    Alice B. Gottlieb
    Nature Reviews Drug Discovery, 2005, 4 : 19 - 34
  • [27] Emerging Preventive Strategies for Preeclampsia
    Provinciatto, Henrique
    Araujo Jr, Edward
    Granese, Roberta
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (12):
  • [28] Emerging Treatment Strategies in AML
    Mueller-Tidow, Carsten
    ANNALS OF HEMATOLOGY, 2019, 98 : S71 - S72
  • [29] Emerging strategies for cancer immunoprevention
    J C Roeser
    S D Leach
    F McAllister
    Oncogene, 2015, 34 : 6029 - 6039
  • [30] Growth strategies and emerging markets
    Artus, P
    REVUE ECONOMIQUE, 1998, 49 (01): : 5 - 8